Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Gilead Sciences
Gilead Sciences
Gilead's Kite exits China cell therapy joint venture with Fosun Pharma
Fierce Pharma
Thu, 09/19/24 - 09:22 pm
Gilead Sciences
Kite Pharma
China
Fosun Kite Biotechnology
Fosun Pharma
Kyverna swaps CEOs, leaning on Kite veterans to lead ‘next chapter’
BioPharma Dive
Mon, 09/16/24 - 10:14 pm
Kyverna Therapeutics
Gilead Sciences
Kite Pharma
CAR-T
cell therapy
Gilead’s twice-yearly shot cut HIV infections by 96% in trial
CNBC
Thu, 09/12/24 - 10:28 am
Gilead Sciences
HIV
lenacapavir
Gilead's Trodelvy triplet underwhelms, but bolsters company's phase 3 lung cancer design
Fierce Pharma
Mon, 09/9/24 - 07:12 pm
Gilead Sciences
Trodelvy
non-small cell lung cancer
Avenzo and Gilead partner for breast cancer combination regimen trial
Clinical Trials Arena
Wed, 09/4/24 - 11:39 am
Avenzo Therapeutics
Gilead Sciences
breast cancer
clinical trials
AVZO-021
Trodelvy
Galapagos Surges On An FDA Win For Its Rival To Gilead, Novartis; But There Are Some Caveats
Investors Business Daily
Mon, 08/26/24 - 11:11 am
Galapagos
CAR-T
FDA
non-Hodgkin lymphoma
Gilead Sciences
Novartis
Gilead’s Livdelzi (Seladelpar) for Primary Biliary Cholangitis Promises Pruritus Reduction
Xtalks
Thu, 08/22/24 - 10:00 pm
FDA
Livdelzi
Gilead Sciences
primary biliary cholangitis
FDA approves Gilead's seladelpar for primary biliary cholangitis
First Word Pharma
Wed, 08/14/24 - 10:35 pm
Gilead Sciences
seladelpar
Livdelzi
liver disease
primary biliary cholangitis
On doorstep of FDA decision, Gilead pays J&J $320M to exit licensing deal for seladelpar
Fierce Biotech
Fri, 08/9/24 - 11:23 am
Gilead Sciences
seladelpar
liver disease
JNJ
Gilead quarterly profit beats Street estimates, revenue up 5%
Yahoo/Reuters
Thu, 08/8/24 - 10:24 pm
Gilead Sciences
earnings
3 Big Pharma companies, 33 phase 3 trials: The race for supremacy in an ADC field
Fierce Pharma
Mon, 08/5/24 - 11:41 am
Merck
AstraZeneca
Gilead Sciences
clinical trials
antibody-drug conjugates
GSK’s Dovato Matches Efficacy of Gilead’s Biktarvy in Head-to-Head HIV Trial
BioSpace
Tue, 07/23/24 - 06:29 pm
GSK
Dovato
Gilead Sciences
Biktarvy
clinical trials
HUV
A new biotech tackling IBD joins a race against Lilly and Gilead for a promising pill
Pharma Voice
Thu, 07/18/24 - 11:12 am
Ensho Therapeutics
IBD
Gilead Sciences
Eli Lilly
Gilead’s CMO to depart next year
BioPharma Dive
Wed, 07/17/24 - 09:11 pm
Gilead Sciences
CMOs
biotech
Gilead set to unveil data from HIV/AIDS trials
Clinical Trials Arena
Wed, 07/17/24 - 12:15 pm
Gilead Sciences
HUV
AIDS
clinical trials
US government appeals Gilead's trial win in Truvada, Descovy patent fight
Fierce Pharma
Tue, 07/9/24 - 12:01 pm
Gilead Sciences
HIV
PrEP
Truvada
Descovy
patents
Gilead’s Trodelvy stumbles in late-stage trials but remains prized cancer asset
BioSpace
Mon, 07/1/24 - 11:39 am
Gilead Sciences
Trodelvy
bladder cancer
lung cancer
clinical trials
Gilead's long-acting HIV drug superior to daily pill Truvada in study
Reuters
Thu, 06/20/24 - 11:20 am
Gilead Sciences
lenacapavir
HIV
Truvada
Gilead’s Magrolimab ineffective, linked to increased risk of death in MDS patients
BioSpace
Mon, 06/17/24 - 11:39 am
Gilead Sciences
clinical trials
patient deaths
MDS
magrolimab
New EHA data reveal how badly Gilead's $4.9B bet on CD47 imploded
Fierce Biotech
Sun, 06/16/24 - 09:04 pm
Gilead Sciences
magrolimab
clinical trials
EHA
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »